Affymetrix Nixes Origin's Higher China-Backed Takeover Bid

Affymetrix decided to accept a lower takeover bid from Thermo Fisher Scientific, rather than a higher offer from former Affymetrix executives that was backed by SummitView Capital, a China private equity firm. Thermo Fisher offered $1.3 billion for Affymetrix while Origin, a special purpose vehicle formed by Centillion executives, upped its bid to $1.6 billion. Affymetrix said it felt the Origen offer was too risky. Although Origin disagreed with the assessment, it withdrew its takeover proposal. More details.... Stock Symbol: (NSDQ: AFFY) Share this with colleagues: // //